FIELD: pharmacology.
SUBSTANCE: one of stent versions contains the following components in terms of the total mass of the alloy: 78.0-91.79 wt % of magnesium, 8.0-12.0 wt % of dysprosium, 0.01-5.0 wt % of neodymium and/or europium 0.1-3.0 wt % of zinc, 0.1-2.0 wt % of zirconium, at that this alloy contains no iron, and the stent is coated by polymers.
EFFECT: group of inventions is characterized by favourable corrosion properties, desirable kinetics of resorption and mechanical properties suitable for obtaining stents.
14 cl, 8 dwg, 5 tbl, 12 ex
| Title | Year | Author | Number |
|---|---|---|---|
| BIODEGRADABLE DEVICE FOR VESSEL LUMEN MAINTENANCE | 2008 |
|
RU2452517C2 |
| MEDICAL DEVICE FOR TREATING LUMEN OBTURATIONS AND PREVENTING THREATENING RECURRENT OBTURATIONS | 2008 |
|
RU2447901C2 |
| MEDICINAL PRODUCT WITH PARTICLE-FREE COATING RELEASING ACTIVE SUBSTANCE | 2011 |
|
RU2578422C2 |
| MAGNESIUM ALLOYS | 2008 |
|
RU2456362C2 |
| MAGNESIUM ALLOY, METHOD OF ITS MANUFACTURE AND USE | 2013 |
|
RU2640700C2 |
| BALLOON CATHETER COATED WITH ANTIRESTENOSIS ACTIVE INGREDIENT AND TRANSPORT PROMOTING MOLECULAR DISPERSING AGENT | 2011 |
|
RU2543330C2 |
| MEDICAL DEVICE FOR TREATING LUMEN OBTURATIONS AND PREVENTING THREATENING RECURRENT OBTURATIONS | 2008 |
|
RU2458710C2 |
| MAGNESIUM ALLOY, METHOD FOR PRODUCTION THEREOF AND USE THEREOF | 2013 |
|
RU2647951C2 |
| MAGNESIUM ALLOY, METHOD FOR ITS PRODUCTION AND USE | 2013 |
|
RU2754035C2 |
| ENDOPROSTHESIS, COATED WITH ACTIVE COMPOUND | 2012 |
|
RU2592367C2 |
